Abstract

10127Background: Regorafenib (REG) is an oral multikinase inhibitor with survival benefit in salvage line therapy for metastatic colorectal cancer (mCRC); fatigue and malaise which are common adver...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
547P - Updated report: A randomized, double-blind, placebo-controlled phase II study of prophylactic dexamethasone (dex) therapy for fatigue and malaise due to regorafenib in patient (pts) with metastatic colorectal cancer (mCRC): (KSCC1402/HGCSG1402)
S Yuki ... Y Maehara
Annals of Oncology | VOL. 27
S Yuki, et. al.S Yuki ... Y Maehara
01 Oct 2016
Serum VEGF-A and CCL5 levels as candidate biomarkers for efficacy and toxicity of regorafenib in patients with metastatic colorectal cancer.
Mitsukuni Suenaga ... Eiji Shinozaki
Oncotarget | VOL. 7
Mitsukuni Suenaga, et. al.Mitsukuni Suenaga ... Eiji Shinozaki
05 May 2016
Chemo-radiotherapy with 177Lu-PLGA(RGF)-CXCR4L for the targeted treatment of colorectal cancer.
Pedro Cruz-Nova ... Clara Santos-Cuevas
Frontiers in Medicine | VOL. 10
Pedro Cruz-Nova, et. al.Pedro Cruz-Nova ... Clara Santos-Cuevas
12 Jun 2023
Bevacizumab in the therapy for refractory metastatic colorectal cancer
Mulcahy
Biologics: Targets & Therapy | VOL. 2
Mulcahy Mulcahy
01 Mar 2008
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Molecular Expression Assays Improve the Prediction of Local and Invasive Local Recurrence After Breast-Conserving Surgery for Ductal Carcinoma In Situ
Ezra Hahn ... Danielle Rodin
Journal of Clinical Oncology | VOL. -
Ezra Hahn, et. al.Ezra Hahn ... Danielle Rodin
28 Jun 2024
Effect of an Invitation or the Effect of Participation: What Should Randomized Controlled Trials of Cancer Screening Examine?
Peter D Sasieni
Journal of Clinical Oncology | VOL. -
Peter D SasieniPeter D Sasieni
28 Jun 2024
Revisiting Timing and Decision Modeling for Allogeneic Hematopoietic Stem-Cell Transplantation in Myelodysplastic Syndromes
Corey Cutler
Journal of Clinical Oncology | VOL. -
Corey CutlerCorey Cutler
28 Jun 2024
Reply to S. Sorscher
Julia Butt ... Meira Epplein
Journal of Clinical Oncology | VOL. -
Julia Butt, et. al.Julia Butt ... Meira Epplein
27 Jun 2024
View more papers